In at PLOS One

Retraction Watch speaks with PLOS One's new editor about the journal's decline in the number of papers published and his plans for the journal.

This Week in PLOS

In PLOS this week: a lung cancer risk-predicting variant in MKK7, mediating infection by pathogenic alphaviruses, and more.

This Week in PLOS

In PLOS this week: researchers explore the transfer of host genetic material into viruses, and more.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.